Medopad rebrands as Huma, acquires UK AI and wearable tech startups

London-based healthcare technology company Medopad has changed its name to Huma and announced acquisition of two UK AI and wearable technology businesses, BioBeats and TLT.

The rebrand and acquisitions support the company's mission to use insights gathered by remote monitoring to help healthcare, life sciences and innovation partners understand, treat and prevent poor health.

By collectively benefiting from the data people individually generate, Huma aims to give knowledge and power to individuals, while saving clinicians time, energy and valuable resources.

Dan Vahdat, founder, CEO, Huma: "We've been through quite a journey since Medopad started in 2011. Medopad has specialised in remote patient monitoring for patients with rare and chronic diseases. Over time, we've realised that health is about more than disease states; it's about general physical and mental wellbeing go hand-in-hand. That's why it makes perfect sense for us to evolve what the company stands for, what we offer, and why we do what we do. That's why from today, Medopad is now Huma. Huma reflects our commitment to working with people, for people. The name Huma says that we're for all of humanity."

BioBeats is a London-based company dedicated to building validated digital mental health interventions and leading a new approach to wellbeing support through its flagship product, BioBase. The mobile app, paired with biosensors and a wearable device, gathers biometric data like heart rate variability and psychometric measures that include mood journaling to provide users with a personalized wellbeing score, fostering an increased understanding of their mental wellbeing. Combining applied research and AI, BioBase improves mental health through tailored insights, biofeedback tools and digital therapeutics for a preventative mental health intervention.

David Plans, co-founder and CEO, BioBeats: "We share a vision with Huma for pioneering preventative health. We want people to go from simply surviving to thriving. By creating clinically-validated products to predict, diagnose and treat mental health disorders, we allow everyone to flourish. We are excited to join Huma to realise our ambition for preventative mental health and wellbeing to people around the world. With Huma's experience, global partners and innovation capabilities, we look forward to joining the Huma team to help people live longer, fuller lives."

TLT is a Hertfordshire-based medical technology company that is pioneering an innovative breakthrough in blood pressure monitoring with an unobtrusive wearable device on a person's wrist. This novel sensor utilises light modulation to detect motion, including continuous beat-by-beat flow motion forces that determine arterial blood pressure. Through this new, clinically-validated technology, it provides continuous blood pressure monitoring without a cuff.

Tamir Strauss, Head of Customer Solutions and Hardware, Huma: "We were attracted to the patented technology and the innovative approach to monitoring blood pressure, a field that has remained unchanged for nearly 100 years. We saw an opportunity to help create new cardiovascular and other digital biomarkers with the unique dataset the device generates."  

www.huma.com

www.biobeats.com